BayPine to acquire CenExel Clinical Research

CenExel’s previous investor Webster Equity Partners will retain a minority stake in the company.

14 April 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.